Cancer

Discovery of how Taxol works could lead to better anticancer drugs

Subtle cell disruption is key to widely-used drug's effectiveness.

Breast cancer research program offers community training

California Breast Cancer Research Program invites people to learn about what environmental factors play role in disease.
Maritza Cardenas

Freshman thrives in research program

Public health program aimed at young women opened the door to undergraduate research and potential medical career.
chest X-ray

Potential lung cancer vaccine shows renewed promise

In mouse studies, an investigational cancer vaccine boosted immune response and reduced the number of tumors.
Hermosa study teen and participant

Taxpayer donations give cancer research a boost

When you file your taxes, consider supporting these programs — simply checking a box can help save lives.

More precise results from robotic-assisted prostate surgery

Using a robotic surgical technique to excise the prostate appears to improve cancer-cell removal and reduce the need for additional post-surgery therapies.
Xiaolin Zi

Can kava cure cancer?

Commonly brewed for tea, the plant compound is being studied for its effectiveness against bladder malignancies.

Experimental treatment eradicates acute leukemia in mice

Using an existing drug and a new drug developed at UCLA, the researchers wiped out cancer cells in mice with a deadly type of blood cancer, leaving healthy blood cells alone. The treatment might also have applications for other blood diseases.

Immunotherapy: the last hope

Patricia Hollowell
Patricia Hollowell gets a hug from her grandson Cody, 3, at her daughter's home in San Rafael, Calif.
Credit: Cindy Chew

Patricia Hollowell, 80, was diagnosed with melanoma in April 2012.

She had three surgeries in quick succession in her hometown of Grand Junction, Colo., that removed the tumors from her head but didn’t prevent them from coming back and spreading quickly to her neck and lymph nodes.

The ultimate betrayal

Robert Bruce and Adil Daud
Robert Bruce meets with Adil Daud, MD, at UCSF Medical Center to discuss the progress of his immunotherapy treatments as part of Daud's clinical trial of the PD-1 antibody.
Credit: Cindy Chew

When Robert Bruce, of El Dorado, Calif., was diagnosed in March 2011 with stage-4 melanoma, he already had tumors on his head, lungs, ribs and lymph nodes.

Pages